How plausible is a link between HSV-1 infection and Alzheimer's disease? (Q51850423)

14 April 2018

editorial

0 references

title

How plausible is a link between HSV-1 infection and Alzheimer's disease? (English)

1 reference

14 April 2018

Herpes simplex virus type 1

main subject

1 reference

1

1 reference

14 April 2018

Mario Clerici

series ordinal

2

1 reference

14 April 2018

Roberta Mancuso

series ordinal

3

1 reference

14 April 2018

publication date

6 February 2014

1 reference

14 April 2018

Expert Review of Anti-infective Therapy

published in

1 reference

14 April 2018

volume

12

1 reference

14 April 2018

issue

3

1 reference

14 April 2018

page(s)

275-278

1 reference

14 April 2018

Intracerebral propagation of Alzheimer's disease: strengthening evidence of a herpes simplex virus etiology

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.887442

Alzheimer's disease and infection: do infectious agents contribute to progression of Alzheimer's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.887442

Seropositivity to herpes simplex virus antibodies and risk of Alzheimer's disease: a population-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.887442

Increase in the IgG avidity index due to herpes simplex virus type 1 reactivation and its relationship with cognitive function in amnestic mild cognitive impairment and Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.887442

Latent herpes simplex virus type 1 in normal and Alzheimer's disease brains

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.887442

Herpes simplex virus infection causes cellular beta-amyloid accumulation and secretase upregulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.887442

APP processing induced by herpes simplex virus type 1 (HSV-1) yields several APP fragments in human and rat neuronal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.887442

Herpes simplex virus type 1 induces nuclear accumulation of hyperphosphorylated tau in neuronal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.887442

Herpes simplex virus dances with amyloid precursor protein while exiting the cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.887442

Herpes simplex virus type I induces the accumulation of intracellular β-amyloid in autophagic compartments and the inhibition of the non-amyloidogenic pathway in human neuroblastoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.887442

Herpes simplex encephalitis affecting the entire limbic system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.887442

Apolipoprotein E genotype influences vertical transmission of herpes simplex virus type 1 in a gender specific manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.887442

Detection of HSV1 DNA by in situ hybridisation in human brain after immunosuppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.887442

Reactivation of herpes simplex virus type 1 is associated with cytomegalovirus and age

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.887442

Time-course of blood-brain barrier disruption in senescence-accelerated mouse prone 8 (SAMP8) mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.887442

Neuroimaging correlates of pathologically defined subtypes of Alzheimer's disease: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.887442

IV immunoglobulin is associated with a reduced risk of Alzheimer disease and related disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.887442

18-Month study of intravenous immunoglobulin for treatment of mild Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.887442

Intravenous immunoglobulins containing antibodies against beta-amyloid for the treatment of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.887442

Alzheimer disease therapy--moving from amyloid-β to tau.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.887442

Intravenous immunoglobulin for treatment of mild-to-moderate Alzheimer's disease: a phase 2, randomised, double-blind, placebo-controlled, dose-finding trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.887442

Intravenous immunoglobulin reduces β amyloid and abnormal tau formation caused by herpes simplex virus type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.887442

Increased permeability of blood–brain barrier on the hippocampus of a murine model of senescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.887442

10.1586/14787210.2014.887442

21 January 2018

Identifiers

DOI

1 reference

14 April 2018

PubMed ID

24502805

1 reference

14 April 2018